... , Marmorstein says. “The metal not only lends a structural support to the inhibitor but also provides the ability to form and accept a wider ... Ruthenium to create a novel scaffold, the platform on which the inhibitor was constructed. After screening a general organometallic library ...
... or no effect on other cells," Shapiro said. "This work sets the stage for further development and testing of these inhibitors ...
... a fellow in Folkman's lab, and one of the first angiogenesis inhibitors to undergo clinical testing. In clinical trials ... oral availability. While a number of angiogenesis inhibitors, such as Avastin, are now commercially available, most target ...
... and hippocampal slices, indicated that exposure to calpain inhibitors restored signaling between nerve cells to normal. The authors therefore suggest that calpain inhibitors improve memory in APP/PS1 mice because ...
... . The investigational drug, motesanib diphosphate, is a VEGF inhibitor, a biologic agent that targets receptors on a protein ...
... five surgeries," Dr. Hamrick says. "Myostatin inhibitors are known to improve muscle regeneration and we have evidence ... by MetaMorphix, Inc. of Beltsville, Md. Both inhibitors have been shown effective in muscle regeneration, but this is the first ...
... say. Bone biologists are studying two myostatin inhibitors in mice with limb injuries, first to see ...
... likely be beneficial to individuals with GBM, these RTK inhibitors have met with limited clinical success — only a small ... by which GBM cells become resistant to RTK inhibitors and have suggested a way to improve the efficacy of RTK ...
... respond to treatment with drugs known as RTK inhibitors, most subsequently relapse after only a short time. New ... by which GBM cells become resistant to RTK inhibitors and suggest a way to improve the efficacy of RTK ...
... , spinal or wrist fractures. The use of proton pump inhibitors has increased in recent years and use is often of indefinite ... administrative database studies have found proton pump inhibitors increase fracture risk. They caution that both ...
... on identifying other agents that could be successfully combined with mTOR inhibitors to halt cancer growth. The new findings ... piece of information into the puzzle of the effects of mTORC1 inhibitors in cell signaling," says Pandolfi. "Furthermore, because ...
... , showing for the first time that vardenafil, a PDE5 inhibitor, is more efficacious when used on-demand in men with erectile dysfunction ... comparison of the currently recommended guidelines for the use of PDE5 inhibitors with a proposed nightly dosing regimen, which was suggested ...
... of the Journal of the National Cancer Institute. ACE inhibitors and ARBs are frequently prescribed medications for the treatment ... , some epidemiological studies in humans suggest that ACE inhibitors and ARBs may reduce the risk of nonmelanoma skin ...
... angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced ...
... no such signal when treated with the small-molecule inhibitor. The findings were published in the September 15 issue ... data from the researchers' ongoing studies suggest that the inhibitor could be used in combination with other chemotherapy drugs to provide a synergistic ...
